Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259T cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein DB, Glod J, Kaplan RN, Grupp SA, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite LN, Amado R, Mackall CL.

Cancer Discov. 2018 Jun 11. pii: CD-17-1417. doi: 10.1158/2159-8290.CD-17-1417. [Epub ahead of print]

PMID:
29891538
2.

Suicidal ideation in lung transplant recipients: A case series.

Rynar LZ, Merchant MS, Dilling DF.

Clin Transplant. 2018 Apr 17:e13263. doi: 10.1111/ctr.13263. [Epub ahead of print]

PMID:
29665073
3.

Dynamic measurement of the optical properties of bovine enamel demineralization models using four-dimensional optical coherence tomography.

Aden A, Anthony A, Brigi C, Merchant MS, Siraj H, Tomlins PH.

J Biomed Opt. 2017 Jul 1;22(7):76020. doi: 10.1117/1.JBO.22.7.076020.

PMID:
28759676
4.

Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.

Majzner RG, Simon JS, Grosso JF, Martinez D, Pawel BR, Santi M, Merchant MS, Geoerger B, Hezam I, Marty V, Vielh P, Daugaard M, Sorensen PH, Mackall CL, Maris JM.

Cancer. 2017 Oct 1;123(19):3807-3815. doi: 10.1002/cncr.30724. Epub 2017 Jun 13.

PMID:
28608950
5.

Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells.

Stroncek DF, Ren J, Lee DW, Tran M, Frodigh SE, Sabatino M, Khuu H, Merchant MS, Mackall CL.

Cytotherapy. 2016 Jul;18(7):893-901. doi: 10.1016/j.jcyt.2016.04.003. Epub 2016 May 17.

6.

MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.

Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J.

Clin Cancer Res. 2016 Aug 1;22(15):3810-20. doi: 10.1158/1078-0432.CCR-15-2717. Epub 2016 Mar 18.

7.

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.

Shah NN, Merchant MS, Cole DE, Jayaprakash N, Bernstein D, Delbrook C, Richards K, Widemann BC, Wayne AS.

Pediatr Blood Cancer. 2016 Jun;63(6):997-1005. doi: 10.1002/pbc.25937. Epub 2016 Feb 17.

PMID:
26891067
8.

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.

Merchant MS, Bernstein D, Amoako M, Baird K, Fleisher TA, Morre M, Steinberg SM, Sabatino M, Stroncek DF, Venkatasan AM, Wood BJ, Wright M, Zhang H, Mackall CL.

Clin Cancer Res. 2016 Jul 1;22(13):3182-91. doi: 10.1158/1078-0432.CCR-15-2550. Epub 2016 Jan 28.

9.

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors.

Merchant MS, Wright M, Baird K, Wexler LH, Rodriguez-Galindo C, Bernstein D, Delbrook C, Lodish M, Bishop R, Wolchok JD, Streicher H, Mackall CL.

Clin Cancer Res. 2016 Mar 15;22(6):1364-70. doi: 10.1158/1078-0432.CCR-15-0491. Epub 2015 Nov 3.

10.

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

Shah NN, Baird K, Delbrook CP, Fleisher TA, Kohler ME, Rampertaap S, Lemberg K, Hurley CK, Kleiner DE, Merchant MS, Pittaluga S, Sabatino M, Stroncek DF, Wayne AS, Zhang H, Fry TJ, Mackall CL.

Blood. 2015 Jan 29;125(5):784-92. doi: 10.1182/blood-2014-07-592881. Epub 2014 Dec 1.

11.

Immune-based therapies for childhood cancer.

Mackall CL, Merchant MS, Fry TJ.

Nat Rev Clin Oncol. 2014 Dec;11(12):693-703. doi: 10.1038/nrclinonc.2014.177. Epub 2014 Oct 28. Review.

PMID:
25348789
12.

What do parents want to know when considering autopsy for their child with cancer?

Wiener L, Sweeney C, Baird K, Merchant MS, Warren KE, Corner GW, Roberts KE, Lichtenthal WG.

J Pediatr Hematol Oncol. 2014 Aug;36(6):464-70. doi: 10.1097/MPH.0000000000000078.

13.

Positron emission tomography for response assessment in desmoplastic small round cell tumor.

Magnan H, Abramson SJ, Price AP, Grewal RK, Merchant MS, LaQuaglia MP, Meyers PA.

J Pediatr Hematol Oncol. 2013 Jul;35(5):e190-3. doi: 10.1097/MPH.0b013e3182707d4c.

PMID:
23073043
14.

Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.

Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL.

J Clin Oncol. 2012 Nov 20;30(33):4141-7. doi: 10.1200/JCO.2012.44.1055. Epub 2012 Oct 15.

15.

Chaperoning the lympho-stromal dance.

Merchant MS.

Blood. 2010 Mar 25;115(12):2334-5. doi: 10.1182/blood-2009-12-254920. No abstract available.

16.

Current approach to pediatric soft tissue sarcomas.

Merchant MS, Mackall CL.

Oncologist. 2009 Nov;14(11):1139-53. doi: 10.1634/theoncologist.2009-0160. Epub 2009 Nov 6. Review.

17.

Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.

Casey DA, Wexler LH, Merchant MS, Chou AJ, Merola PR, Price AP, Meyers PA.

Pediatr Blood Cancer. 2009 Dec;53(6):1029-34. doi: 10.1002/pbc.22206.

PMID:
19637327
18.

Long-term impact of cancer care on activities of daily living: are we causing our sarcoma survivors to grow up too quickly?

Merchant MS.

Pediatr Blood Cancer. 2009 Oct;53(4):531-2. doi: 10.1002/pbc.22166. No abstract available.

PMID:
19588522
19.

Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.

Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL.

Nat Immunol. 2009 Feb;10(2):149-57. doi: 10.1038/ni.1695. Epub 2009 Jan 11.

20.

Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.

Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL.

Cancer Immunol Immunother. 2007 Jul;56(7):1037-46. Epub 2006 Dec 6.

PMID:
17149595
21.

Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma.

Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL.

Cancer Res. 2004 Nov 15;64(22):8349-56.

22.

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.

Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ.

J Natl Cancer Inst. 2004 Jan 7;96(1):46-55.

PMID:
14709738
23.

Tumor expression of 4-1BB ligand sustains tumor lytic T cells.

Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL.

Cancer Biol Ther. 2003 Sep-Oct;2(5):579-86.

PMID:
14614331
24.

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.

Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA.

Oncogene. 2003 Apr 17;22(15):2334-42.

PMID:
12700668
26.

Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.

Merchant MS, Woo CW, Mackall CL, Thiele CJ.

J Natl Cancer Inst. 2002 Nov 20;94(22):1673-9.

PMID:
12441322
29.

Supplemental Content

Loading ...
Support Center